Salt‐Inducible Kinase 2‐Triggered Release of Its Inhibitor from Hydrogel to Suppress Ovarian Cancer Metastasis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Salt‐Inducible Kinase 2‐Triggered Release of Its Inhibitor from Hydrogel to Suppress Ovarian Cancer Metastasis
Authors
Keywords
-
Journal
Advanced Science
Volume -, Issue -, Pages 2202260
Publisher
Wiley
Online
2022-05-27
DOI
10.1002/advs.202202260
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peptide-based supramolecular hydrogels for local drug delivery
- (2021) Zhenghao Zhang et al. ADVANCED DRUG DELIVERY REVIEWS
- Nuts and bolts of the salt-inducible kinases (SIKs)
- (2021) Nicola J. Darling et al. BIOCHEMICAL JOURNAL
- Supramolecular hydrogels of self-assembled zwitterionic-peptides
- (2021) Yiming Zhang et al. CHINESE CHEMICAL LETTERS
- Cancer statistics for the year 2020: An overview
- (2021) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Intracellular Nanoparticle Formation and Hydroxychloroquine Release for Autophagy‐Inhibited Mild‐Temperature Photothermal Therapy for Tumors
- (2021) Ge Gao et al. ADVANCED FUNCTIONAL MATERIALS
- Triple Enzyme‐Regulated Molecular Hydrogels for Carrier‐Free Delivery of Lonidamine
- (2021) Can Wu et al. ADVANCED FUNCTIONAL MATERIALS
- Structure-Based Design of Selective Salt-Inducible Kinase Inhibitors
- (2021) Roberta Tesch et al. JOURNAL OF MEDICINAL CHEMISTRY
- Efficient protein incorporation and release by a jigsaw-shaped self-assembling peptide hydrogel for injured brain regeneration
- (2021) Atsuya Yaguchi et al. Nature Communications
- A sandcastle worm-inspired strategy to functionalize wet hydrogels
- (2021) Donghui Zhang et al. Nature Communications
- Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
- (2020) Anniina Färkkilä et al. Nature Communications
- Supramolecular prodrug hydrogelator as an immune booster for checkpoint blocker–based immunotherapy
- (2020) Feihu Wang et al. Science Advances
- Supramolecular Tubustecan Hydrogel as Chemotherapeutic Carrier to Improve Tumor Penetration and Local Treatment Efficacy
- (2020) Feihu Wang et al. ACS Nano
- Supramolecular Nanofibers Containing Arginine-Glycine-Aspartate (RGD) Peptides Boost Therapeutic Efficacy of Extracellular Vesicles in Kidney Repair
- (2020) Chuyue Zhang et al. ACS Nano
- The progress and perspective of nanoparticle-enabled tumor metastasis treatment
- (2020) Wei Zhang et al. Acta Pharmaceutica Sinica B
- Challenges for immunotherapy for the treatment of platinum resistant ovarian cancer
- (2020) Olivia Le Saux et al. SEMINARS IN CANCER BIOLOGY
- Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer
- (2020) Szymon Piatek et al. Journal of Ovarian Research
- Intracellular Self‐Assembly of Peptide Conjugates for Tumor Imaging and Therapy
- (2020) Yu Deng et al. Advanced Healthcare Materials
- Nanoparticles in precision medicine for ovarian cancer: From chemotherapy to immunotherapy
- (2020) Yuan Li et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Receptor tyrosine kinases-instructed release of its inhibitor from hydrogel to delay ovarian aging
- (2020) Zhonghua Shi et al. BIOMATERIALS
- Epigenetic therapy for ovarian cancer: promise and progress
- (2019) Sara Moufarrij et al. Clinical Epigenetics
- Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status
- (2019) Angiolo Gadducci et al. Journal of Ovarian Research
- Epithelial ovarian cancer
- (2019) Stephanie Lheureux et al. LANCET
- Sustained Release of Two Bioactive Factors from Supramolecular Hydrogel Promotes Periodontal Bone Regeneration
- (2019) Jiali Tan et al. ACS Nano
- Current status and future prospects of PARP inhibitor clinical trials in ovarian cancer
- (2019) Xuan Jiang et al. Cancer Management and Research
- Stimuli-responsive Biomolecule-based Hydrogels and their Applications
- (2019) Margarita Vázquez-González et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer
- (2019) Tian Gao et al. CANCER LETTERS
- Immune Responsive Release of Tacrolimus to Overcome Organ Transplant Rejection
- (2018) Jindao Wu et al. ADVANCED MATERIALS
- Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Robert L Coleman et al. LANCET
- Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in Vivo
- (2016) Thomas B. Sundberg et al. ACS Chemical Biology
- Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche
- (2016) Fabrizio Miranda et al. CANCER CELL
- Aromatic–Aromatic Interactions Enable α-Helix to β-Sheet Transition of Peptides to Form Supramolecular Hydrogels
- (2016) Jie Li et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Supramolecular biomaterials
- (2016) Matthew J. Webber et al. NATURE MATERIALS
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ovarian cancer
- (2016) Ursula A. Matulonis et al. Nature Reviews Disease Primers
- Designing hydrogels for controlled drug delivery
- (2016) Jianyu Li et al. Nature Reviews Materials
- Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
- (2015) Xuewen Du et al. CHEMICAL REVIEWS
- Supramolecular amplification of amyloid self-assembly by iodination
- (2015) Arianna Bertolani et al. Nature Communications
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- β-Turn structure in glycinylphenylalanine dipeptide based N-amidothioureas
- (2013) Xiao-Sheng Yan et al. CHEMICAL COMMUNICATIONS
- Latest research and treatment of advanced-stage epithelial ovarian cancer
- (2013) Robert L. Coleman et al. Nature Reviews Clinical Oncology
- Optimal first-line treatment in ovarian cancer
- (2012) F. A. Raja et al. ANNALS OF ONCOLOGY
- First-line Chemotherapy in Epithelial Ovarian Cancer
- (2012) MICHAEL A. BOOKMAN CLINICAL OBSTETRICS AND GYNECOLOGY
- Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages
- (2012) K. Clark et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started